LifeStance Health Group Sees Unusually High Options Volume (NASDAQ:LFST)

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) was the target of unusually large options trading activity on Tuesday. Stock investors purchased 4,000 put options on the company. This is an increase of 292% compared to the average daily volume of 1,020 put options.

LifeStance Health Group Stock Performance

Shares of NASDAQ LFST traded down $0.10 during midday trading on Friday, hitting $6.64. 2,298,738 shares of the company's stock traded hands, compared to its average volume of 1,573,602. The firm has a fifty day moving average of $7.47 and a 200 day moving average of $7.34. LifeStance Health Group has a 1 year low of $4.64 and a 1 year high of $8.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a market capitalization of $2.55 billion, a price-to-earnings ratio of -25.54 and a beta of 1.30.

Insiders Place Their Bets

In related news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the transaction, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 6.60% of the stock is currently owned by insiders.

Remove Ads

Institutional Investors Weigh In On LifeStance Health Group

Hedge funds have recently modified their holdings of the business. Intech Investment Management LLC purchased a new stake in LifeStance Health Group in the third quarter worth about $311,000. Charles Schwab Investment Management Inc. increased its holdings in LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company's stock worth $7,731,000 after acquiring an additional 297,723 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in LifeStance Health Group by 10.5% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company's stock worth $572,000 after acquiring an additional 7,798 shares during the period. Townsquare Capital LLC purchased a new position in LifeStance Health Group during the third quarter valued at approximately $73,000. Finally, MetLife Investment Management LLC boosted its position in shares of LifeStance Health Group by 14.3% in the third quarter. MetLife Investment Management LLC now owns 80,422 shares of the company's stock worth $563,000 after purchasing an additional 10,084 shares during the period. Institutional investors own 85.50% of the company's stock.

Analyst Ratings Changes

LFST has been the subject of a number of recent analyst reports. The Goldman Sachs Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 target price for the company in a report on Monday, December 16th. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a research report on Thursday. They set a "buy" rating and a $8.00 target price for the company. Finally, William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.